The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCTP.L Regulatory News (CTP)

  • There is currently no data for CTP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Options

21 Jul 2015 07:00

RNS Number : 5732T
Castleton Technology PLC
21 July 2015
 

Castleton Technology Plc

 ("Castleton" or "the Company")

Grant of Options

 

As outlined in the circular to shareholders dated 9 June 2015, Castleton, the software and managed services provider to the public and not for profit sectors, announces that on 18 July 2015 it awarded options over 8.6% of the fully diluted share capital in the Company ("Options") to Haywood Chapman (Chief Financial Officer), Davinder Sanghera (Chief Operating Officer), David Payne (Non-Executive Director), Phil Kelly (Non-Executive Director) and MXC Guernsey Limited ("MXC").

The Options have been granted as follows:

· to Haywood Chapman, Options over 2% of the fully diluted share capital under a combination of EMI Share Options, Unapproved Share Options and Employee Share Scheme Options;

 

· to Davinder Sanghera, Options over 1% of the fully diluted share capital under a combination of EMI Share Options, Unapproved Share Options and Employee Share Scheme Options;

 

· to David Payne, Options over 0.4% of the fully diluted share capital under a combination of Unapproved Share Options and Hurdle Shares;

 

· to Phil Kelly, Options over 0.2% of the fully diluted share capital under a combination of Unapproved Share Options and Hurdle Shares; and

 

· to MXC, Options over 5% of the fully diluted share capital of the Company under the MXC Share Option Scheme.

All of the Options are evergreen, meaning that the percentage of the fully diluted issued share capital held under option will remain constant, notwithstanding any further issues of ordinary shares of 0.1 pence in the capital of the Company ("Ordinary Shares"). The Options are being awarded under a variety of schemes, both approved and unapproved. All of the Options are subject to vesting criteria whereby the average price of Ordinary Share must exceed 3 pence, and in some cases 4 pence, for a 10 day period between the second and third anniversaries of 1 April 2015.

If the average price of an Ordinary Share does not reach or exceed the targets above then the Option shall lapse.

The award of these Options has been delayed due to the Company being in a close period resulting from the half year results and recent acquisition activity.

Related Party Transaction

The grant of options to MXC is deemed to be a related party transaction Under the AIM Rules for Companies as they are equivalent to 5% of the fully diluted share capital of the Company. Accordingly the independent directors, for these purposes being Haywood Chapman, Davinder Sanghera, David Payne and Phil Kelly, consider, having consulted with finnCap, the Company's nominated adviser, that the terms of the share option award to MXC are fair and reasonable insofar as the Company's shareholders are concerned.

 

 

Enquiries:

Castleton Technology plc

Ian Smith, Chief Executive

Haywood Chapman, Chief Financial Officer

Tel. 44 (0)20 7965 8149

http://www.castletonplc.com

 

finnCap Ltd

Geoff Nash / Simon Hicks

Tel. +44 (0)20 7220 0500

MXC Capital Advisory LLP

Marc Young / Charlotte Stranner

Tel. +44 (0)20 7965 8149

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBRGDRDSDBGUG
Date   Source Headline
7th Mar 20177:00 amRNSDirector Dealings/ Holdings in Company
6th Mar 20177:00 amRNSDirector Dealings/Holdings in Company
2nd Mar 20177:00 amRNSDirector Dealings & Holdings in Company
8th Feb 20173:54 pmRNSHolding(s) in Company
27th Jan 20177:00 amRNSDirector Dealings/ Holdings in Company
19th Jan 20174:21 pmRNSHolding(s) in Company
19th Jan 20174:20 pmRNSDirector/PDMR Shareholding
16th Jan 20177:01 amRNSDirectorate Change
16th Jan 20177:00 amRNSContract Wins
21st Dec 20169:18 amRNSHolding(s) in Company
22nd Nov 20164:28 pmRNSHolding(s) in Company
15th Nov 20167:06 amRNSContract Win
14th Nov 201610:00 amRNSGrant of Options
14th Nov 20167:00 amRNSHalf-year Report
31st Oct 20167:00 amRNSBoard Changes
26th Oct 20168:30 amRNSHolding(s) in Company
4th Oct 201611:37 amRNSIssue of Equity/Conversion of Loan Notes
29th Sep 20164:06 pmRNSResult of AGM
26th Sep 20164:32 pmRNSHolding(s) in Company
9th Sep 20167:00 amRNSPosting of Annual Report and Notice of AGM
31st Aug 20167:00 amRNSDirectorate Change
16th Aug 20167:00 amRNSFinal Results
5th Jul 20164:36 pmRNSIssue of Equity/Conversion of Loan Notes
3rd May 20164:34 pmRNSHolding(s) in Company
3rd May 20167:00 amRNSTrading Update
21st Apr 20167:00 amRNSHolding(s) in Company
4th Apr 20167:00 amRNSLicense Agreement
29th Mar 20163:04 pmRNSHolding(s) in Company
15th Mar 20167:00 amRNSContract wins
8th Feb 20164:45 pmRNSHolding(s) in Company
1st Feb 20167:00 amRNSAcquisition of Kypera Holdings Limited
28th Jan 20165:26 pmRNSHolding(s) in Company
28th Jan 20165:00 pmRNSHolding(s) in Company
27th Jan 20164:10 pmRNSStatement re Share Price Movement
31st Dec 20157:00 amRNSExercise of Warrants / Issue of Equity
24th Dec 201512:29 pmRNSHolding(s) in Company
24th Dec 20157:00 amRNSGrant of Options
17th Dec 20154:56 pmRNSHolding(s) in Company
16th Dec 20157:00 amRNSIssue of Equity / Conversion of Loan Notes
15th Dec 20157:00 amRNSHalf Yearly Report
15th Dec 20157:00 amRNSFurther re: Acquisition of Opus
2nd Nov 20157:00 amRNSAppointment of Director
22nd Oct 20154:20 pmRNSResult of AGM and Capital Reorganisation
22nd Oct 20157:00 amRNSTrading Update
13th Oct 20154:25 pmRNSHolding(s) in Company
1st Oct 201512:13 pmRNSExercise of Options / Issue of Equity
30th Sep 20154:41 pmRNSProposed Capital Reorganisation
21st Sep 20157:00 amRNSFinal Results
14th Sep 20153:25 pmRNSPartnership with solutions supplier
2nd Sep 20155:54 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.